Flora Growth Corp. (ZSTK) Stock Analysis & Investment Frameworks
Flora Growth Corp. (ZSTK) stock analysis on Invetso. Review Flora Growth Corp.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Flora Growth Corp. Company Overview
- Exchange: NASDAQ
- Sector: Financial Services
- Industry: Asset Management
- Country: CA
Flora Growth Corp. Key Financial Metrics
- Market Cap: $87.19M
- Revenue: $35.68M
- ROE: -382.27%
- ROIC: -66.34%
- Dividend Yield: N/A
About Flora Growth Corp.
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
Flora Growth Corp. Investment Frameworks
Invetso analyzes Flora Growth Corp. (ZSTK) across the following frameworks:
- Flora Growth Corp. 10Y Growth Potential
- Flora Growth Corp. Scenario Analysis
- Flora Growth Corp. Risks & Opportunities
- Flora Growth Corp. Economic Moat
- Flora Growth Corp. Business Model
- Flora Growth Corp. Management
- Flora Growth Corp. SWOT Analysis
- Flora Growth Corp. Porter's 5 Forces
- Flora Growth Corp. PESTLE Analysis
- Flora Growth Corp. ESG Analysis